You are viewing an expired study

This study is not currently recruiting Study Participants on If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Memphis, Tennessee 38105

  • occlusive Disease


Veno-occlusive disease (VOD) of the liver is a significant complication for some patients undergoing hematopoietic stem cell transplantation. This disease is thought to be a toxicity secondary to chemotherapy or radiation-induced damage to the epithelial cells of the blood vessels in the liver. VOD is categorized as mild, moderate or severe. Historically, there has been no method to treat the disease. Recently, however, there have been investigations into the use of a new agent called defibrotide. The primary purpose of this protocol is to provide defibrotide to patients with severe VOD. Because this drug has not been approved by the FDA, use of this medication under the auspices of this IND treatment plan is for compassionate use only.

Study summary:

Secondary objectives of this protocol include the following: - To describe the toxicities of defibrotide in patients with VOD. - To describe the response rate of VOD in patients receiving defibrotide.


Inclusion Criteria: Patients with clinical or pathologic diagnosis of veno-occlusive disease. The following criteria will be used: 1. Hyperbilirubinemia (greater than or equal to 2mg/dl) and two of the following: (hepatomegaly, ascites, or weight gain [greater than or equal to 5% of baseline]); OR, 2. Patient who do not fulfill criteria in #1 but who have pathologic or radiographic evidence of VOD.



Primary Contact:

Principal Investigator
Wing Leung, M.D.
St. Jude Children's Research Hospital

Backup Contact:


Location Contact:

Memphis, Tennessee 38105
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.